Michael Bronstein

Michael Bronstein, Scientific Director AI of AITHYRA, the new Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences will bring world-leading expertise in developing novel machine learning technique for biological applications, as well as a track record of research commercialization and technological spinoffs and industrial experience to Vienna.

Michael Bronstein is Scientific Director AI of AITHYRA and DeepMind Professor of AI at the University of Oxford. His research interests lie in geometric deep learning, graph neural networks, 3D shape analysis, protein design, non-human species communication. Michael Bronstein was previously Head of Graph Learning Research at Twitter, a Professor at Imperial College London and held visiting appointments at Stanford, MIT, and Harvard. Michael Bronstein received his PhD from the Technion Israel Institute of Technology in 2007. He is the recipient of the EPSRC Turing AI World Leading Research Fellowship, Royal Society Wolfson Research Merit Award, Royal Academy of Engineering Silver Medal, five ERC grants, two Google Faculty Research Awards, and two Amazon AWS ML Research Awards. He is a Member of the Academia Europaea, Fellow of IEEE, IAPR, BCS, and ELLIS, ACM Distinguished Speaker, and World Economic Forum Young Scientist. In addition to his academic career, Michael Bronstein is a serial entrepreneur and founder of multiple startup companies, including Novafora, Invision (acquired by Intel in 2012), Videocites, and Fabula AI (acquired by Twitter in 2019).